Process line for the production of freeze-dried particles
10006706 ยท 2018-06-26
Assignee
Inventors
Cpc classification
F26B5/06
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
International classification
Abstract
A process line (300) for the production of freeze-dried particles under closed conditions is provided, the process line comprising at least the following separate devices: a spray chamber (302) for droplet generation and freeze congealing of the liquid droplets to form particles, and a bulk freeze-dryer (304) for freeze drying the particles, wherein a transfer section (308) is provided for a product transfer from the spray chamber (302) to the freeze-dryer (304), for the production of the particles under end-to-end closed conditions each of the devices (302, 304) and of the transfer section (308) is separately adapted for closed operation, and the spray chamber (302) is adapted for separation of the liquid droplets from any cooling circuit.
Claims
1. A process line for the production of freeze-dried particles under closed conditions, the process line comprising at least the following separate process devices: a spray chamber for generation of discrete liquid droplets and freeze congealing of the liquid droplets to form particles; and a bulk freeze-dryer for freeze drying the particles; wherein a transfer section is provided for a product transfer from the spray chamber to the freeze-dryer; for the production of the particles under end-to-end closed conditions each of the process devices and of the transfer section is separately adapted for closed operation, the spray chamber comprises a double wall with an outer wall and a cooled inner wall encompassing an inner volume, said double wall defining an internal volume and said inner wall being cooled by a cooling circuitry comprising a tube system extending throughout at least a part of said internal volume of said double wall, said inner volume providing a non-circulating medium, said cooled inner wall and said non-circulating medium being the only cooling component for freezing the droplets, for avoiding a counter- or concurrent cooling flow.
2. The process line according to claim 1, wherein the process devices and the transfer section form an integrated process line providing end-to-end protection of sterility of the product and/or end-to-end containment of the product.
3. The process line according to claim 1, wherein the transfer section comprises means for operatively separating the process devices from each other such that the at least one of the process devices is operable under closed conditions separately from the other process device without affecting the integrity of the process line.
4. The process line according to claim 3, wherein the means for operatively separating the process devices from each other is a vacuum-tight valve.
5. The process line according to claim 1, wherein at least one of the process devices and the transfer section comprises a confining wall which is adapted for providing predetermined process conditions within a confined process volume, wherein the confining wall is adapted for isolating the process volume and an environment of the process devices from each other.
6. The process line according to claim 1, wherein the process devices and the transfer section form an integrated process line providing end-to-end protection of sterility of the product and/or end-to-end containment of the product.
7. The process line according to claim 1, wherein the freeze-dryer is adapted for separated operation under closed conditions, the separated operation including at least one of particle freeze-drying, cleaning of the freeze-dryer, and sterilization of the freeze-dryer.
8. The process line according to claim 1, wherein the process line comprises as a further process device a product handling device adapted for at least one of discharging the product from the process line, taking product samples, and manipulating the product under closed conditions.
9. The process line according to claim 1, wherein the spray chamber comprises at least one temperature-controlled wall for freeze congealing the liquid droplets.
10. The process line according to claim 1, wherein the freeze-dryer is a vacuum freeze-dryer.
11. The process line according to claim 1, wherein the freeze-dryer comprises a rotary drum for receiving the particles.
12. The process line according to claim 11, wherein the particles have a tendency to be generally spherical.
13. The process line according to claim 1, wherein the transfer section of the process line comprises at least one temperature-controlled wall.
14. The process line according to claim 1, wherein the entire process line is adapted for Cleaning in Place CiP and/or Sterilization in Place SiP.
15. The process line according to claim 14, wherein the at least one temperature-controlled wall is an actively cooled inner wall of the transfer section.
16. The process line according to claim 1, wherein the liquid droplets freeze during their fall in the spray chamber in order to form frozen particles.
17. A process for the production of freeze-dried particles under closed conditions performed by a process line according to claim 1, the process comprising at least the following process steps: generating liquid droplets and freeze congealing of the liquid droplets form particles in a spray chamber; transferring the product under closed conditions from the spray chamber to a freeze-dryer via a transfer section; and freeze drying the particles as bulkware in the freeze-dryer, wherein for the production of the particles under end-to-end closed conditions each of the process devices and of the transfer section is separately adapted for closed operation.
18. The process according to claim 17, wherein the product transfer to the freeze-dryer is performed in parallel to droplet generation and freeze-congealing in the spray chamber.
19. The process according to claim 17, comprising a step of operatively separating spray chamber and freeze-dryer to perform Cleaning in Place CiP and/or Sterilization in Place SiP in one of the process devices.
20. A process for preparing a vaccine composition comprising one or more antigens in the form of freeze-dried particles comprising: freeze-drying a liquid bulk solution comprising said one or more antigens according to the process as described in claim 17, and filling the freeze-dried particles obtained into a recipient.
21. A process according to claim 20, wherein all the steps of the process line are carried out under sterile conditions.
22. A process for preparing an adjuvant containing vaccine composition comprising one or more antigens in the form of freeze-dried particles comprising: a. freeze-drying a liquid bulk solution comprising said adjuvant and said one or more antigens according to the process as described in claim 17, and b. filling the freeze-dried particles obtained into a recipient; or alternatively when the liquid bulk solution of a) does not comprise said adjuvant, c. freeze-drying separately a liquid bulk of said adjuvant and a liquid bulk solution comprising said one or more antigens according to the process as described in claim 17, d. blending the freeze dried particles of said one or more antigens with the freeze dried particles of adjuvant, and e. filling the blending of freeze-dried particles into a recipient.
23. A process according to claim 22, wherein the freeze-dried particles are sterile.
24. The process according to claim 17, wherein the liquid droplets freeze during their fall in the spray chamber in order to form frozen particles.
Description
DESCRIPTION OF THE FIGURES
(1) Further aspects and advantages of the invention will become apparent from the following description of particular embodiments illustrated in the figures in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
(12)
(13) Closure 104 is intended to indicate that the product flow 100 from entry to exit of process line 102 is performed under closed conditions, i.e., the product is kept under sterility and/or containment. In preferred embodiments, the process line provides closed conditions without the use of an isolator (the role of which is as indicated by dashed line 108 which separates line 100 from environment 110). Instead, closure 104 separates product flow 100 from environment 110, wherein closure 104 (closed conditions) is/are implemented individually for each of the devices and transfer sections of process line 102. Further, the goal of end-to-end protection of sterility and/or containment is achieved without putting the entire process within one single device. Instead, the process line 100 according to the invention comprises separate process devices (e.g., one or more PTs, FDs, DSs, etc.) which are connected as indicated in
(14)
(15) The details of how process devices such as PTs or FDs can protect sterility/provide containment for the products processed therein depend on the specific application. For example, in one embodiment, the sterility of a product is protected/maintained by sterilizing the involved process devices and transfer sections. It is to be noted that a process volume confined within a hermetically closed wall will after a sterilization process be considered sterile during a given time under particular processing conditions, such as, but not limited to, processing of the product under slight excess (positive) pressure compared to an environment 215. Containment can be considered to be achieved by processing the product under slightly lowered pressure compared to the environment 215. These and other appropriate processing conditions are known to the skilled person.
(16) As a general remark, transfer sections such as 1TS and 2TS depicted in
(17)
(18) Similarly, FD 210 forms a further closed subsystem which is separated: (1) from the environment 215; and (2) from the other adjoining process devices separated by 1TS 208 and 2TS 212. It is assumed that the process devices of process line 200 are optimized to be compliant with cleaning and/or sterilization CiP/SiP procedures. Correspondingly, a CiP/SiP system 216 is provided which includes a system of pipes for providing a cleaning/sterilization medium to each of the process devices. The piping system is indicated with dashed lines in
(19) As schematically indicated in the figures, the enclosures 204-214 provide an entirely closed outer envelope 222 encompassing the process line 200. The transfer sections 208 and 212 interconnect the process devices while maintaining closed conditions for the product transfer throughout the process line 200. The envelope 222 is unchanged from
(20) It is further to be noted that the closure envelope 222 of process line 200 depicted in
(21)
(22) The configuration illustrated in
(23) Generally, the process line 200 as variously depicted in
(24) In various preferred embodiments, the process line 200 is permanently mechanically integrated, thus negating the requirements for disassembling the various process devices, which is conventionally required, e.g., after a production run for performing a cleaning/sterilization of the process line.
(25) The design principles of process line 200 also allow for in-process-control of relevant process/product parameters since the devices can operatively be separated from each other (e.g., via the operation of one or more transfer sections) and can be run in different operational modes and/or process/product control modes can be performed and optimized individually for the separate process devices. The control facilities of process line 200 are preferably adapted to separately drive operational modes for each of the process devices and transfer sections of the line.
(26)
(27) The liquid feeding section 301 indicated only schematically in
(28) The freezing of droplets in a spray device such as prilling tower 302 may be achieved, for example, such that the diluted composition, i.e., the formulated liquid product, is sprayed and/or prilled. Prilling may be defined as a (for example, frequency-induced) break-up of a constant liquid flow into discrete droplets. Prilling does not exclude use of other droplet generation techniques such as use of hydraulic nozzles, two-component nozzles, etc. Generally, the goal of spraying and/or prilling is to generate calibrated droplets with diameter ranges for example from 200 m to 1500 m, with a narrow size distribution of +/25%, more preferably +/10%. The droplets fall in the prilling tower in which a spatial temperature profile is maintained with, for example a value of between 40 C. to 60 C., preferably between 50 C. and 60 C., in a top area and between 150 C. to 192 C., for example between 150 C. and 160 C., in a bottom area of the tower. Lower temperatures ranges can be obtained in the tower by alternative cooling systems for example, a cooling system using helium. The droplets freeze during their fall in order to form preferably round, calibrated frozen particles (i.e., micropellets).
(29) Specifically, the prilling tower 302 preferably comprises side walls 320, a dome 322 and a bottom 324. The dome 322 is equipped with a droplet generation system 326 according to one or more of the aspects discussed above and may for example comprise one or more nozzles for generation of droplets from a liquid (e.g., via atomization) provided to the system 326 from the liquid feeding section 301. The droplets are frozen on their way down to the bottom 324.
(30) A cut-out illustration of a particular embodiment of prilling tower wall 320 is depicted in
(31) As generally shown in
(32) Cooling the inner volume 328 of prilling tower 302 sufficient for freezing the falling droplets 323 (cf.
(33) The cooling medium circulating inside coils 408 may generally be liquid and/or gaseous. The cooling medium circulating inside tubing 408 may comprise nitrogen, e.g., may comprise a nitrogen/air mixture, and/or brine/silicon oil, which is input into the coil system 408 via inflow 410. The present invention is not limited, however, to the exemplary cooling mediums mentioned above.
(34) The droplet generation system 326 arranged with the dome 322 may for example comprise one or more high-frequency nozzles for transforming the flowable material (e.g., liquids and/or pastes) to be pilled into droplets. With regard to exemplary numerical values, the high frequency nozzles may have an operating range of between 1-4 kHz at a throughput of 5-30 g/min per nozzle with a liquid of solid content ranging from 5-50% (w/w).
(35) The droplets 323 are frozen on their gravity-induced fall within the prilling tower 302 due to cooling mediated by the temperature-controlled wall 320 of the prilling tower 302 and an appropriate non-circulating atmosphere provided within the internal volume 328, for example, an (optionally sterile) nitrogen and/or air atmosphere. In one exemplary embodiment, in the absence of further cooling mechanisms, forming freezing droplets into round micropellets with sizes/diameters in the range of 100-800 m an appropriate height of the prilling tower is between 1-2 m (meters) while forming freezing droplets into pellets with a size range up to 1500 m (micrometers) the prilling tower is between about 2-3 m wherein the diameter of the prilling tower can be between about 50-150 cm for a height of 200-300 cm. The temperatures in the prilling tower can optionally be maintained or varied/cycled throughout between about 50 C. to 190 C.
(36) The frozen droplets/micropellets 323 reach the bottom 324 of the prilling tower 302. In the embodiment discussed here, the product is then automatically transferred by gravity towards and into transfer section 308.
(37) The transfer section 308 as illustrated in
(38) As illustrated in
(39) Permanent connections can be achieved with welding. In other embodiments, permanent connections, which are intended to be permanent during production runs, cleaning, sterilization, etc., but which can be disassembled for purposes of inspection, revision, validation, etc., can be achieved with screwing and/or bolting. Sealing technologies which may be applied in conjunction with the aforementioned techniques in order to provide the prerequisite for closed conditions (sterile and/or containment conditions) include, but are not limited to, flat seals or gaskets, or flange connections, and the like. Any sealing material should be absorption-resistant and should withstand low temperatures in order to avoid embrittling and/or attrition with risk of product pollution resulting there from. Also adhesive bonding may be employed as long as any adhesive is emission-free.
(40) It is noted that a sealing property is understood as leakage-free for gas, liquids, and solids, to be maintained for pressure differences of, for example, atmospheric conditions on one side and vacuum conditions on the other side, wherein vacuum may mean a pressure as low as 10 millibar, or 1 millibar, or 500 microbar, or 1 microbar.
(41) The separation component 336 is adapted for controllably providing an operative separation between prilling tower 302 and freeze-dryer 304. For example, the separation component 336 may comprise a closing device for closing up a transfer device such as a tube. Embodiments of closing devices include, but are not limited to, sealable separation means, such as a flap gate, lid, or valve. Non-limiting examples for suitable valve-types comprise butterfly valves, squeeze valves, and knife gate valves and the like.
(42) Closed conditions can be preserved not only with respect to an environment of the process line 300, the requirement of operative separation can also include the requirement of a sterile/contained enclosure between the devices 302 and 304. For example, a vacuum-tight seal or lock can be provided in the separation component 336 in this respect. This may enable, for example, a freeze-drying batch mode production run in freeze-dryer 304 under vacuum, while a higher pressure, e.g., atmospheric pressure or hyperbaric pressure, is maintained in a separate component (e.g., the prilling tower 302) of the process line while it is engaged in another operational mode such as prilling, cleaning, or sterilization. Generally, separation means 336 can be adapted to separate various operational modes from each other, such that operative separation includes the sealable separation of operative conditions such as pressure (with vacuum or overpressure conditions on one side), temperature, humidity, etc.
(43)
(44) Provision of the two separating means, 506 and 508, with intermediary storage component 510 therefore provides further configuration options over that of mandatory direct transferring of the product from prilling tower 302 into freeze-dryer 304 as with the transfer section 308 in
(45) Generally, transfer section 500 is designed to preserve closed conditions (i.e., sterile conditions and/or containment) during transfer (and storage) of product between the process devices connected at inflow 502 and outflow 504, respectively. In this way, section 500 contributes to preserving process line end-to-end closed conditions. This particular feature of transfer section 500 is illustrated in
(46) The transfer section 500, as illustrated in
(47) While the exemplary transfer sections illustrated in
(48) Referring back to
(49) Accordingly, the freeze-dryer 304 is equipped with rotary drum 366 which due to its rotation provides for a large effective drying surface of the product and therefore fast drying compared to vial-based and/or tray-based drying. Embodiments of rotary drum drying devices, which may be suitable depending on the individual case, include, but are not limited to, vacuum drum dryers, contact-vacuum drum dryers, convective drum dryers, and the like. A specific rotary drum dryer is described, for example, in the DE 196 54 134 C2.
(50) The term effective product surface is understood herein as referring to the product surface which is in fact exposed and therefore available for heat and mass transfer during the drying process, wherein the mass transfer may in particular include an evaporation of sublimation vapour. While the present invention is not limited to any particular mechanism of action or methodology, it is contemplated that rotation of the product during the drying process exposes more product surface area (i.e., increases the effective product surface) than conventional vial-based and/or tray-based drying methodologies (including, e.g., vibrated tray-drying). Thus, utilization of one or more rotary-drum-based drying devices can lead to shorter drying cycle times than conventional vial-based and/or tray-based drying methodologies.
(51) In preferred embodiments, besides process devices such as the prilling tower 302 and transfer sections such as the transfer section 308, the freeze-dryer 304 is also separately configured for operation under closed conditions. The freeze-dryer 304 is adapted for performing at least the operations of pellet freeze-drying, optionally automatic cleaning of the freeze-dryer in place, and automatic sterilization of the freeze-dryer in place.
(52) Specifically, in certain embodiments, freeze-dryer 304 comprises a first chamber 362 and a second chamber 364, wherein first chamber 362 comprises a rotary drum 366 for receiving the product from prilling tower 302, and second chamber 364 comprises a condenser 368 and a vacuum pump for providing a vacuum in internal volume 370 of chamber 362 and internal volume 372 of drum 366. Valve 371 is provided for separating chambers 362 and 364 according to different operational modes of the freeze-dryer 304. Chamber 362 and/or 364 can be referred to as vacuum chambers as used herein by virtue of their operation.
(53) In preferred embodiments, vacuum chamber 362 comprises a double walled structure having an outer wall 374 and an inner wall 376 being constructed similarly as illustrated in
(54) The drum 366 is supported in its rotational movement by supporting elements 380. Drum 366 has a free opening 382 so that pressure conditions (such as vacuum conditions), temperature conditions, etc., are promoted between internal volumes 370 and 372. In freeze-drying operation, for example, the vapour resulting from sublimation is drawn from volume 370 of drum 366 containing the pellets to be freeze-dried into volume 370 of the vacuum chamber 362 and further to chamber 364.
(55) Outflow 334 of transfer section 308 comprises a protrusion 384 protruding into drum 366 of freeze-dryer 304 for guiding the product into the drum 366. As drum 366 is fully contained within vacuum chamber 362, it is not necessary to further isolate or separate the drum 366; in other words, the function of providing closed conditions for processing inside device 304 is with vacuum chamber 362. Therefore, in certain embodiments outflow 334 of transfer section 308 can be permanently connected to vacuum chamber 362 in this way. A complex mounting or docking/undocking arrangement between stationary transfer section 308 and rotating drum 366 is not required. According to the various embodiments of the present invention the sterile and/or contained transfer of product from prilling tower 302 into the rotary drum 366 of freeze-dryer 304 is reliably and cost-effectively implemented.
(56) Further embodiments provide freeze-dryer 304 being specifically adapted for closed operation (i.e., for operation preserving sterility of the product to be freeze-dried and/or containment) wherein chambers 362 and 364 are designed for implementing an appropriately closed housing. Fixation means 386 can be provided at the freeze-dryer 304 for permanently connecting with the transfer section 308, in particular the fixation means 338 of transfer section 308, wherein the fixation means 338 and 386 are adapted to ensure, when affixed to each other, sterility and/or containment for the product transition from the transfer section 308 into freeze-dryer 304. Fixing means 338 and means 386 together may comprise welding, riveting, bolting, etc.
(57) Transfer section 310 connects freeze-dryer 304 and discharge station 306. Unloading of drum 366 can be achieved, for example, by providing one or more of the following: 1) a discharge opening (either opening 382 and/or an opening in a cylindrical section of drum 366); 2) providing a discharge guiding means; and 3) inclining drum 366. The unloaded pellets can then flow with/out the assistance of gravity and/or one or more mechanical conveyances from chamber 362 via transfer section 310 into discharge station 306.
(58) The discharge station 306 comprises one or more filling means 390 provided for dispensing the product received from the freeze-dryer 304 into recipients 392. Recipients 392 may comprise final recipients such as vials or intermediate recipients such as Intermediate Bulk Containers (IBCs). Similar to other process devices (e.g., devices 302 and 304), discharge station 306 is adapted for operation under closed conditions, such that, for example, a sterile product can be filled into a recipient 392 under sterile conditions. The discharge station 306 in the embodiment shown in
(59) Freeze-dryer 304 and discharge station 306 are permanently connected via transfer section 310. Transfer section 310 comprises inflow 3102, outflow 3104 and separating means 3106. Transfer section 310 may be similar in design to transfer section 308. However, while transfer section 310 may be provided with double walls, cooling circuitry may be omitted either in outflow 3104 or in both inflow 3102 and outflow 3104, since in many cases dried product ready for discharge no longer requires cooling. Still then, double walls can be used to install/enclose sensor linings and pipelines for cleaning and/or sterilization (e.g., conducting cleaning and/or sterilization media), and/or can be used to reliably implement the closed conditions for protecting sterility of and/or providing containment for the product flow from the freeze-dryer 304 to the discharge station 306.
(60)
(61) A sterilization chamber 608 can be loaded with one or more IBCs 606 via sealable gate 610. Chamber 608 has a further sealable gate 612 which when open allows transfer of IBCs between vacuum chamber 602 and sterilization chamber 608. After loading IBCs 606 from the environment via gate 610 into chamber 608, the IBCs 606 can be sterilized by means of sterilization equipment 616, which can, for example, be connected to a sterilization means also supplying sterilization media to SiP equipment of freeze-dryer 600. After sterilization of IBCs 606, gate 612 is opened and IBCs 606 are moved into the vacuum chamber 602 of freeze-dryer 600 by use of a mechanical conveyance (e.g., a traction system) 618.
(62) Rotary drum 604 can optionally be equipped with a peripheral opening 620, as schematically indicated in
(63) Transfer sections such as sections 308 and 310 described in process line 300 (
(64) It is to be noted that the freeze-dryers illustrated in
(65) Referring again to
(66)
(67) When the prilling process in the prilling tower 302 is finalized and the frozen pellets generated therein have been transferred entirely into the freeze-dryer 304, as operatively illustrated in step 708 of
(68) In step 714 the freeze-dried product is discharged from the freeze-dryer 304 into the discharge station 306. Step 714 can be performed after step 712 is completed, but can also be performed in parallel to step 710. Discharging step 714 may comprise opening the transfer section 310. In order for a preservation of closed conditions, e.g., sterility, the discharge station 306 can be cleaned and/or sterilized prior to opening the transfer section 310.
(69) After discharging is completed in step 714 and the entire batch production (or a portion thereof) is filled into one or more recipients 392, transfer section 310 can be configured to operatively separate the freeze-dryer 304 from the discharge station 306. In step 716, CiP and/or SiP can then be performed in the freeze-dryer 304. After de-loading filled recipients 392 from the discharge station 306, CiP/SiP can also be performed in the discharge station 306 either in parallel to steps 716 and/or 710 in freeze-dryer 304 or subsequently. As soon as steps 710 and 716 are finalized, the operation 700 of process line 300 has finalized and the process line 300 can be available for the next production run. Cleaning and/or sterilization steps 710 and 716 can be performed at any time, but are preferably performed prior to the beginning of a production run.
(70) However, in other embodiments, subsequent production runs can commence without cleaning and/or sterilization of the freeze-dryer 304 being finalized (as in step 716 in
(71) An exemplary operational scheme 730 is likewise illustrated in
(72) After step 734 is finished, the transfer section 308 can be opened in step 736 allowing a product flow of the frozen pellets produced in step 732 and loading thereof into rotary drum 366. While step 736 has to follow step 734 in order for protection of sterility of the product, step 732 can be performed with any time relation to step 736, e.g., the prilling can start before or after opening the transfer section in step 736. Depending on process line configurations and parameters, it may be advantageous to fill the frozen pellets into a slowly rotating drum, as this is contemplated to help avoid particle (e.g., pellets or micropellets) agglomerations. Therefore, in certain embodiments, in step 706 and/or step 736 the rotary drum 366 is kept rotating. Further, the product transfer performed in step 706 and/or step 736 can be performed continuously during (i.e., in parallel to) the spray freezing in step 704 and/or step 732.
(73) In a modified embodiment of process line 300, transfer section 500 of
(74) In another modified embodiment, the prilling tower continues prilling and feeding temporary storage 512 of transfer section 500 with frozen pellets, while the frozen pellets are batch-wise unloaded from the storage 512 into freeze-dryer 304 according to the capacity of freeze-dryer 304. Thus, production rates of prilling tower 302 and freeze-dryer 304, respectively, can be decoupled to some degree including (quasi)continuous and batchwise operational modes of the process devices can be coupled within the process line in cases of accordingly adapted and/or controllable transfer sections. Transfer sections do not may or may not be equipped with temporary storage as illustrated in
(75) The exemplary embodiments described herein are intended to illustrate the flexibility of process line concepts according to the invention. For instance, providing end-to-end closed conditions by process devices each specifically adapted for operation under closed conditions and permanently interconnecting these devices with transfer sections also adapted for protection of sterility and/or preservation of containment, avoids the necessity of employing one or more isolators for achieving closed conditions. A process line according to the invention can be operated in a non-sterile environment for manufacturing a sterile product. This leads to corresponding advantages in analytical requirements and associated costs. Further, preferred embodiments avoid the difficulties experienced in typical process lines employing multiple isolators that arise during product handling while bridging the interfaces between the various isolators. The process lines according to the invention are thus not limited by available isolator size, and in principle there are no size limits on process lines adapted for operation under closed conditions. The invention contemplates that considerable cost reductions are possible in typical fully conforming GMP, GLP (Good Laboratory Practice), and/or GCP (Good Clinical Practice), and international equivalents, manufacturing processes and operations, by avoiding the necessity of using a plurality of costly isolators.
(76) In these or other embodiments, while the inventive process line concepts provide for an integrated system, for example, in the sense of end-to-end closed conditions, the process devices such as prilling tower (or other spray chamber device) and freeze-dryer are clearly kept separate from each other and are also operatively separable by function of the interconnected transfer sections. In this way, the disadvantages of highly integrated systems wherein the entire process is performed within a single specifically adapted device are avoided. Keeping multiple process devices as separate units allows one to separately optimize each of the process devices with regard to its specific functionality. For example, according to one embodiment of the invention, it is contemplated that a process line comprising a freeze-dryer comprising a rotary drum provides comparatively faster drying times than conventional methodologies. In further embodiments, separate optimization of process devices such as the prilling tower and/or the freeze-dryer allows for separate optimization of the cooling mechanisms applied. As illustrated in the examples, it is possible to provide process lines that do not need a sterile cooling medium such as liquid/gaseous nitrogen (mixtures), which correspondingly reduces production costs. As the inventive concepts are applicable to bulkware production, the process lines need not be adapted to any specific recipients such as IBCs or vials, and, in a further example, specific stoppers for drying in vials are not required. If desired, a process line can be adapted to specific recipients, but this may concern merely the device concerned with discharging, e.g., a discharge station of the line.
(77) The products resulting from process lines adapted according to the invention can comprise virtually any formulation in liquid or flowable paste state that is suitable also for conventional (e.g., shelf-type) freeze-drying processes, for example, monoclonal antibodies, protein-based APIs, DNA-based APIs, cell/tissue substances, vaccines, APIs for oral solid dosage forms such as APIs with low solubility/bioavailability, fast dispersible oral solid dosage forms like ODTs, orally dispersible tablets, stick-filled adaptations, etc., as well as various products in the fine chemicals and food products industries. In general, suitable flowable materials for prilling include compositions that are amenable to the benefits of the freeze-drying process (e.g., increased stability once freeze-dried).
(78) The invention allows the generation of, for example, sterile lyophilized and uniformly calibrated particles, e.g., micropellets, as bulkware. The resulting product can be free-flowing, dust-free and homogeneous. Such products have good handling properties and can be easily combined with other components, wherein the components might be incompatible in liquid state or only stable for a short time period and thus otherwise not suitable for conventional freeze-drying. Certain process lines can thus provide a basis for a separation of filling processes and prior drying processes, i.e., filling-on-demand becomes practically feasible. The relatively time-consuming manufacture of bulkware can readily be performed even if the dosing of the API is still to be defined. Different filling compositions/levels can easily be realized without the requirement for another liquid composition, spraying, drying and subsequent filling. The time-to-market can be reduced correspondingly.
(79) Specifically, the stability of a variety of products can be optimized (e.g., including, but not limited to, single or multivariant vaccines with or without adjuvants). Conventionally, it has been known that freeze-drying is performed as a final step in the pharmaceutical industry which conventionally follows filling the product into vials, syringes, or larger containers. The dried product has to be rehydrated before its use. Freeze-drying in the form of particles, particularly in the form of micropellets allows similar stabilization of, for example, a dried vaccine product as known for mere freeze-drying alone, or it can improve stability for storage. The freeze-drying of bulkware (e.g., vaccine or fine chemical micropellets) offers several advantages in comparison to conventional freeze-drying; for example, but not limited to, the following: it allows the blending of the dried products before filling, it allows titers to be adjusted before filling, it allows minimizing the interaction(s) between any products, such that the only product interaction occurs after rehydration, and it allows in many cases an improvement in stability.
(80) In fact, the product to be bulk freeze-dried, can result from a liquid containing, for example, antigens together with an adjuvant, the separate drying of the antigens and the adjuvant (in separate production runs, which can, however, be performed on the same process line according to the invention), followed by blending of the two ingredients before the filling or by a sequential filling. In other words, the stability can be improved by generating separate micropellets of antigens and adjuvant, for example. The stabilizing formulation can be optimized independently for each antigen and the adjuvant. The micropellets of antigens and adjuvant can subsequently be filled into the final recipients or can be blended before filling into the recipients. The separated solid state allows one to avoid throughout storage (even at higher temperature) interactions between antigens and adjuvant. Thus, configurations might be reached, wherein the content of the vial can be more stable than any other configurations. Interactions between components can be standardized as they occur only after rehydration of the dry combination with one or more rehydrating agents such as a suitable diluent (e.g., water or buffered saline).
(81) In order to support a permanently mechanically integrated system providing end-to-end sterility and/or containment, additionally, a specific cleaning concept for the entire process line is contemplated. In a preferred embodiment, a single steam generator, or similar generator/repository for a cleaning/sterilization medium is provided which via appropriate pipings serves the various process devices including the transfer sections of the line. The cleaning/sterilization system can be configured to perform automatic CiP/SiP for parts of the line or the entire line, which avoids the necessity of complex and time-consuming cleaning/sterilization processes which require disassembly of the process line and/or which have to be performed at least in part manually. In certain embodiments, cleaning/sterilization of isolators is not required or avoided completely. Cleaning/sterilization of only a part of the process line can be performed, while other parts of the line are in different operational modes, including, running at full processing capability. Conventional, highly integrated systems normally offer only the possibility to clean and/or sterilize the entire system at once.
(82) Accordingly, the subject matter of the invention is relating to a process for preparing a vaccine composition comprising one or more antigens in the form of freeze-dried particles comprising: Freeze-drying a liquid bulk solution comprising one or more antigens according to the process of the invention, and Filling the freeze-dried particles obtained into a recipient.
(83) In a further aspect the invention is relating to a process for preparing an adjuvant containing vaccine composition comprising one or more antigens in the form of freeze-dried particles comprising: Freeze-drying a liquid bulk solution comprising an adjuvant and one or more antigens according to the process according to the invention, and Filling the freeze-dried particles obtained into a recipient.
(84) Alternatively when the one or more antigens and the adjuvant are not in the same solution, the process for preparing an adjuvant containing vaccine composition comprises: Freeze-drying separately a liquid bulk of adjuvant and a liquid bulk solution comprising one or more antigens according to the process of the invention, Blending the freeze dried particles of said one ore more antigens with the freeze dried particles of said adjuvant, and Filling the blending of freeze-dried particles into a recipient.
(85) The liquid bulk solution of antigen(s) may contain for instance killed, live attenuated viruses or antigenic component of viruses like Influenza virus, Rotavirus, Flavivirus (including for instance dengue (DEN) viruses serotypes 1, 2, 3 and 4, Japanese encephalitis (JE) virus, yellow fever (YF) virus and West Nile (WN) virus as well as chimeric flavivirus), Hepatitis A and B virus, Rabies virus. The liquid bulk solutions of antigen(s) may also contain killed, live attenuated bacteria, or antigenic component of bacteria such as bacterial protein or polysaccharide antigens (conjugated or non-conjugated), for instance from serotype b Haemophilus influenzae, Neisseria meningitidis, Clostridium tetani, Corynebacterium diphtheriae, Bordetella pertussis, Clostridium botulinum, Clostridium difficile.
(86) A liquid bulk solution comprising one or more antigens means a composition obtained at the end of the antigen production process. The liquid bulk solution of antigen(s) can be a purified or a non purified antigen solution depending on whether the antigen production process comprises a purification step or not. When the liquid bulk solution comprises several antigens, they can originate from the same or from different species of microorganisms. Usually, the liquid bulk solution of antigen(s) comprises a buffer and/or a stabilizer that can be for instance a monosaccharide such as mannose, an oligosaccharide such as sucrose, lactose, trehalose, maltose, a sugar alcohol such as sorbitol, mannitol or inositol, or a mixture of two or more different of these aforementioned stabilizers such as a mixture of sucrose and trehalose. Advantageously, the concentration of monosaccharide oligosaccharide, sugar alcohol or mixture thereof in the liquid bulk solution of antigen(s) ranges from 2% (w/v) to the limit of solubility in the formulated liquid product, more particularly it ranges from 5% (w/v) to 40% (w/v), 5% (w/v) to 20% (w/v) or 20% (w/v) to 40% (w/v). Compositions of liquid bulk solutions of antigen(s) containing such stabilizers are described in particular in WO 2009/109550, the subject matter of which is incorporated by reference.
(87) When the vaccine composition contains an adjuvant it can be for instance: 1) a particulate adjuvant such as: liposomes and in particular cationic liposomes (e.g. DC-Chol, see e.g. US 2006/0165717, DOTAP, DDAB and 1,2-Dialkanoyl-sn-glycero-3-ethylphosphocholin (EthylPC) liposomes, see U.S. Pat. No. 7,344,720), lipid or detergent micelles or other lipid particles (e.g. Iscomatrix from CSL or from Isconova, virosomes and proteocochleates), polymer nanoparticles or microparticles (e.g. PLGA and PLA nano- or microparticles, PCPP particles, Alginate/chitosan particles) or soluble polymers (e.g. PCPP, chitosan), protein particles such as the Neisseria meningitidis proteosomes, mineral gels (standard aluminum adjuvants: AlOOH, AlPO.sub.4), microparticles or nanoparticles (e.g. Ca.sub.3(PO.sub.4).sub.2), polymer/aluminum nanohybrids (e.g. PMAA-PEG/AlOOH and PMAA-PEG/A1PO.sub.4 nanoparticles) O/W emulsions (e.g. MF59 from Novartis, AS03 from GlaxoSmithKline Biologicals) and W/O emulsion (e.g. ISA51 and ISA720 from Seppic, or as disclosed in WO 2008/009309). For example, a suitable adjuvant emulsion for the process according to the present invention is that disclosed in WO 2007/006939. 2) a natural extracts such as: the saponin extract QS21 and its semi-synthetic derivatives such as those developed by Avantogen, bacterial cell wall extracts (e.g. micobacterium cell wall skeleton developed by Corixa/GSK and micobaterium cord factor and its synthetic derivative, trehalose dimycholate). 3) a stimulator of Toll Like Receptors (TLR). It is particular natural or synthetic TLR agonists (e.g. synthetic lipopeptides that stimulate TLR2/1 or TLR2/6 heterodimers, double stranded RNA that stimulates TLR3, LPS and its derivative MPL that stimulate TLR4, E6020 and RC-529 that stimulate TLR4, flagellin that stimulates TLR5, single stranded RNA and 3M's synthetic imidazoquinolines that stimulate TLR7 and/or TLR8, CpG DNA that stimulates TLR9, natural or synthetic NOD agonists (e.g. Muramyl dipeptides), natural or synthetic RIG agonists (e.g. viral nucleic acids and in particular 3 phosphate RNA).
(88) When there is no incompatibility between the adjuvant and the liquid bulk solution of antigen(s) it can be added directly to the solution. The liquid bulk solution of antigen(s) and adjuvant may be for instance a liquid bulk solution of an anatoxin adsorbed on an aluminium salt (alun, aluminium phosphate, aluminium hydroxide) containing a stabilizer such as mannose, an oligosaccharide such as sucrose, lactose, trehalose, maltose, a sugar alcohol such as sorbitol, mannitol or inositol, or a mixture thereof. Examples of such compositions are described in particular in WO 2009/109550, the subject matter of which is incorporated by reference.
(89) The freeze-dried particles of the non adjuvanted or adjuvanted vaccine composition are usually under the form of spheric particles having a mean diameter between 200 m and 1500 m. Furthermore since the process line according to the invention has been designed for the production of particles under closed conditions and can be sterilized, advantageously, the freeze-dried particles of the vaccine compositions obtained are sterile.
(90) While the current invention has been described in relation to its preferred embodiments, it is to be understood that this description is for illustrative purposes only.
(91) This application claims priority of European patent application EP 11 008 057.9-1266, the subject-matters of the claims of which are listed below for the sake of completeness: 1. A process line for the production of freeze-dried particles under closed conditions, the process line comprising at least the following separate devices: a spray chamber for droplet generation and freeze congealing of the liquid droplets to form particles; and a bulk freeze-dryer (304) for freeze drying the particles; wherein a transfer section is provided for a product transfer from the spray chamber to the freeze-dryer, and for the production of the particles under end-to-end closed conditions each of the devices and of the transfer section is separately adapted for closed operation. 2. The process line according to item 1, wherein the transfer section permanently interconnects the two devices to form an integrated process line for the production of the particles under end-to-end closed conditions. 3. The process line according to item 2, wherein the transfer section comprises means for operatively separating the two connected devices from each other such that at least one of the two devices is operable under closed conditions separately from the other device without affecting the integrity of the process line. 4. The process line according to any one of the preceding items, at least one of the process devices and the transfer section comprises a confining wall which is adapted for providing predetermined process conditions within a confined process volume, wherein the confining wall is adapted for isolating the process volume and an environment of the process device from each other. 5. The process line according to any one of the preceding items, wherein the process devices and the transfer section form an integrated process line providing end-to-end protection of sterility of the product and/or end-to-end containment of the product. 6. The process line according to any one of the preceding items, wherein the freeze-dryer is adapted for separated operation under closed conditions, the separated operation including at least one of particle freeze-drying, cleaning of the freeze-dryer, and sterilization of the freeze-dryer. 7. The process line according to any one of the preceding items, wherein the integrated process line comprises as further device a product handling device adapted for at least one of discharging the product from the process line, taking product samples, and manipulating the product under closed conditions. 8. The process line according to any one of the preceding items, wherein the spray chamber (comprises at least one temperature-controlled wall for freeze congealing the liquid droplets. 9. The process line according to any one of the preceding items, wherein the freeze-dryer is a vacuum freeze-dryer. 10. The process line according to any one of the preceding items, wherein the freeze-dryer comprises a rotary drum for receiving the particles. 11. The process line according to any one of the preceding items, wherein at least one of the one or more transfer sections of the process line comprises at least one temperature-controlled wall. 12. The process line according to any one of the preceding items, wherein the entire process line is adapted for Cleaning in Place CiP and/or Sterilization in Place SiP. 13. A process for the production of freeze-dried particles under closed conditions performed by a process line according to any one of the preceding items, the process comprising at least the following process steps: generating liquid droplets and freeze congealing of the liquid droplets to form particles in a spray chamber; transferring the product under closed conditions from the spray chamber to a freeze-dryer via a transfer section; and freeze drying the particles as bulkware in the freeze-dryer;
(92) wherein for the production of the particles under end-to-end closed conditions each of the devices and of the transfer section is separately operated under closed conditions. 14. The process according to item 13, wherein the product transfer to the freeze-dryer is performed in parallel to droplet generation and freeze-congealing in the spray chamber. 15. The process according to any one of items 13 and 14, comprising a step of operatively separating spray chamber and freeze-dryer to perform CiP and/or SiP in one of the separated devices.